Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and due from banks	$ 18,053	$ 10,082
Interest bearing deposits with banks	265,138	181,525
Cash and cash equivalents	283,191	191,607
Investment securities available for sale, at fair value	26,022	26,613
Investment securities held to maturity (fair value of $1,441 at March 31, 2020 and $1,430 at December 31, 2019)	1,181	1,167
Total investment securities	27,203	27,780
Loans held for sale	193	190
Loans, net of unearned income	1,468,204	1,420,749
Less: Allowance for loan losses	(23,219)	(21,811)
Net loans	1,444,985	1,398,938
Accrued interest receivable	6,358	6,069
Premises and equipment, net	6,901	6,946
Other real estate owned	3,950	4,727
Restricted stock	7,440	7,440
Bank owned life insurance (BOLI)	26,556	26,410
Deferred tax asset	6,117	6,285
Other	2,662	4,768
Total Assets	1,815,556	1,681,160
Deposits
Noninterest-bearing deposits	351,892	259,269
Interest-bearing deposits	1,117,438	1,079,950
Total deposits	1,469,330	1,339,219
FHLBNY borrowings	134,650	134,650
Subordinated debentures	13,403	13,403
Accrued interest payable	1,968	2,260
Other	11,335	12,204
Total liabilities	1,630,686	1,501,736
Equity
Preferred stock,1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 500 shares outstanding at March 31, 2020 and December 31, 2019, respectively	500	500
Common stock, $.10 par value; authorized 15,000,000 shares; Issued:12,133,640 shares and 12,132,855 shares at March 31, 2020 and Dec. 31, 2019, respectively	1,213	1,213
Additional paid-in capital	134,769	134,706
Retained earnings	49,449	44,143
Accumulated other comprehensive income	573	58
Treasury stock, 284,522 shares at March 31, 2020 and Dec. 31, 2019, at cost	(3,015)	(3,015)
Total shareholders’ equity	183,489	177,605
Noncontrolling interest in consolidated subsidiaries	1,381	1,819
Total equity	184,870	179,424
Total liabilities and equity	$ 1,815,556	$ 1,681,160